Dan Brennan

Stock Analyst at TD Securities

(3.91)
# 589
Out of 4,893 analysts
107
Total ratings
48.84%
Success rate
11.17%
Average return

Stocks Rated by Dan Brennan

Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $56$60
Current: $51.04
Upside: +17.55%
GeneDx Holdings
May 1, 2025
Maintains: Buy
Price Target: $135$110
Current: $91.88
Upside: +19.72%
Maravai LifeSciences Holdings
Mar 21, 2025
Maintains: Neutral
Price Target: $8$2.5
Current: $2.76
Upside: -9.42%
Tempus AI
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $58.41
Upside: +26.69%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $82$86
Current: $55.31
Upside: +55.49%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $155$175
Current: $161.75
Upside: +8.19%
Charles River Laboratories International
Nov 7, 2024
Maintains: Buy
Price Target: $240$250
Current: $158.97
Upside: +57.26%
Bruker
Nov 6, 2024
Maintains: Hold
Price Target: $72$70
Current: $42.12
Upside: +66.19%
Illumina
Nov 5, 2024
Maintains: Buy
Price Target: $166$177
Current: $97.44
Upside: +81.65%
Revvity
Nov 5, 2024
Maintains: Buy
Price Target: $141$144
Current: $100.13
Upside: +43.81%
Maintains: Hold
Price Target: $363$410
Current: $349.21
Upside: +17.41%
Maintains: Buy
Price Target: $310$315
Current: $200.96
Upside: +56.75%
Maintains: Buy
Price Target: $153$160
Current: $121.30
Upside: +31.90%
Maintains: Hold
Price Target: $28$30
Current: $5.72
Upside: +424.48%
Maintains: Buy
Price Target: $28$31
Current: $13.57
Upside: +128.45%
Maintains: Buy
Price Target: $648$658
Current: $419.88
Upside: +56.71%
Maintains: Buy
Price Target: $48$51
Current: $42.61
Upside: +19.69%
Initiates: Buy
Price Target: $2.8
Current: $0.32
Upside: +785.80%
Maintains: Buy
Price Target: $21$20
Current: $7.53
Upside: +165.60%
Downgrades: Hold
Price Target: $57$32
Current: $12.10
Upside: +164.46%
Maintains: Outperform
Price Target: $545$546
Current: $235.89
Upside: +131.46%
Initiates: Outperform
Price Target: $7
Current: $2.20
Upside: +218.18%
Upgrades: Outperform
Price Target: $13$15
Current: $1.48
Upside: +913.51%
Upgrades: Buy
Price Target: $207$232
Current: $150.53
Upside: +54.12%
Downgrades: Sell
Price Target: $770$880
Current: $1,218.65
Upside: -27.79%